Villalas, Diosdado C.
HRN: 22-45-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/07/2023
01/14/2023
IV
600mg
Q6
DM FOOT
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes